![The ticker and trading information for Blackstone Group is displayed at the post where it is traded on the floor of the New York Stock Exchange](https://www.msn.com/{"default":{"load":"default","w":"80","h":"53","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB1a4sGE.img?h=533&w=799&m=6&q=60&o=f&l=f"},"size3column":{"load":"default","w":"62","h":"42","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB1a4sGE.img?h=416&w=624&m=6&q=60&o=f&l=f"},"size2column":{"load":"default","w":"62","h":"42","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB1a4sGE.img?h=416&w=624&m=6&q=60&o=f&l=f"}})
© Reuters/Brendan McDermid
The ticker and trading information for Blackstone Group is displayed at the post where it is traded on the floor of the New York Stock Exchange
(Reuters) – Blackstone Real Estate Partners and co-investors have agreed to sell BioMed Realty for $14.6 billion to a group led by existing BioMed investors, Blackstone Group Inc said on Thursday.
Blackstone had agreed to buy BioMed Realty, a supplier of office space to healthcare companies, in late 2015 in a deal valued at $8 billion. (https://reut.rs/341V5a3)
Video: Europe’s Top Fintech Unicorn: Klarna CEO on $10.6 billion valuation, fundraising mega-round (CNBC)
UP NEXT
Blackstone said on Thursday it is commencing a “go-shop” process on behalf of BioMed’s current investors, with the recapitalization expected to close within five business days after the process concludes.
(Reporting by Kanishka